{
  "id": "d738f4b40fb111cd",
  "title": "STAT+: FDA\u2019s new \u2018plausible mechanism pathway\u2019 for personalized gene editing raises concerns",
  "description": "A new FDA pathway meant to enable one-time gene-editing cures could, ethicists warn, become a Pandora's box.",
  "content": "A new FDA pathway meant to enable one-time gene-editing cures could, ethicists warn, become a Pandora's box.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/26/fda-makary-prasad-crispr-gene-editing-concerns-baby-kj/?utm_campaign=rss",
  "published_at": "2026-01-26T09:30:00+00:00",
  "fetched_at": "2026-01-27T00:25:22.667063+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: FDA\u2019s new \u2018plausible mechanism pathway\u2019 for personalized gene editing raises concerns",
    "description": "A new FDA pathway meant to enable one-time gene-editing cures could, ethicists warn, become a Pandora's box.",
    "url": "https://www.statnews.com/2026/01/26/fda-makary-prasad-crispr-gene-editing-concerns-baby-kj/?utm_campaign=rss",
    "published": "2026-01-26T09:30:00+00:00",
    "source": "STAT"
  }
}